B. Riley Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,880
Closed -$291K 558
2019
Q4
$291K Buy
+6,880
New +$255K 0.04% 295

Other funds holding SBIO

B. Riley Wealth Management's SBIO Position: Q1 2020 in Review

B. Riley Wealth Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2020, closing a stake of 6,880 shares — an estimated $291K sold.

B. Riley Wealth Management first reported a position in SBIO in Q4 2019 and held it in 1 quarter. The position peaked at $291K in Q4 2019. 47 funds tracked by Wall St. Rank hold SBIO as of Q1 2020.

  • B. Riley Wealth Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2020 after selling out during the quarter.
  • B. Riley Wealth Management sold 6,880 ALPS Medical Breakthroughs ETF shares in Q1 2020, an estimated $291K.
  • B. Riley Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2019 and held it in 1 quarter.
  • B. Riley Wealth Management's ALPS Medical Breakthroughs ETF position peaked at $291K in Q4 2019.
  • 47 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2020.

Based on B. Riley Wealth Management's 13F filing for Q1 2020, filed 15 May 2020.